PCVX [NASD]
Vaxcyte, Inc.
Index- P/E- EPS (ttm)-2.19 Insider Own1.50% Shs Outstand57.55M Perf Week2.36%
Market Cap1.30B Forward P/E- EPS next Y-2.81 Insider Trans-12.53% Shs Float50.28M Perf Month-19.41%
Income-117.80M PEG- EPS next Q-0.69 Inst Own89.20% Short Float4.03% Perf Quarter-11.54%
Sales- P/S- EPS this Y36.20% Inst Trans10.22% Short Ratio5.25 Perf Half Y-9.74%
Book/sh6.25 P/B3.33 EPS next Y-3.60% ROA-32.80% Target Price48.50 Perf Year-13.17%
Cash/sh5.35 P/C3.89 EPS next 5Y4.70% ROE-37.20% 52W Range16.78 - 27.44 Perf YTD-12.40%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-24.05% Beta-
Dividend %- Quick Ratio12.60 Sales past 5Y- Gross Margin- 52W Low24.20% ATR1.47
Employees89 Current Ratio12.60 Sales Q/Q- Oper. Margin- RSI (14)48.29 Volatility6.63% 7.63%
OptionableYes Debt/Eq0.00 EPS Q/Q-63.40% Profit Margin- Rel Volume0.98 Prev Close20.52
ShortableYes LT Debt/Eq0.00 EarningsMay 09 AMC Payout- Avg Volume386.05K Price20.84
Recom1.50 SMA201.58% SMA50-8.81% SMA200-9.45% Volume378,712 Change1.56%
Dec-29-21Resumed Jefferies Buy $50
Jun-24-21Resumed Jefferies Buy $50
Jul-07-20Initiated Needham Buy $40
Jul-07-20Initiated Cantor Fitzgerald Overweight $55
Jul-07-20Initiated BofA Securities Buy $37
Jun-27-22 07:30PM  
Jun-02-22 04:05PM  
May-09-22 04:10PM  
May-04-22 01:34PM  
May-03-22 08:30AM  
Apr-05-22 08:30AM  
Apr-04-22 08:30AM  
Mar-08-22 04:59AM  
Feb-28-22 04:10PM  
Feb-23-22 04:05PM  
Feb-17-22 08:30AM  
Feb-10-22 08:30AM  
Jan-31-22 07:00AM  
Jan-13-22 07:09AM  
01:07AM  
Jan-12-22 04:10PM  
Jan-06-22 08:30AM  
Dec-31-21 10:00AM  
Nov-15-21 10:23AM  
Nov-11-21 04:05PM  
Nov-10-21 04:10PM  
Oct-28-21 08:30AM  
Oct-04-21 10:04AM  
Sep-30-21 11:17AM  
Sep-28-21 04:05PM  
Sep-21-21 04:01PM  
Sep-20-21 04:30PM  
Sep-13-21 10:35AM  
Aug-11-21 04:07PM  
Aug-05-21 08:30AM  
Aug-03-21 09:01AM  
May-27-21 04:05PM  
May-11-21 04:10PM  
May-10-21 08:30AM  
May-06-21 04:05PM  
Apr-05-21 04:30PM  
Mar-29-21 04:10PM  
02:30PM  
Mar-25-21 07:11AM  
06:48AM  
Mar-22-21 04:05PM  
Mar-15-21 06:34AM  
Jan-06-21 08:15AM  
Dec-22-20 08:00AM  
Dec-10-20 06:34PM  
Nov-24-20 04:05PM  
Nov-12-20 04:15PM  
Nov-10-20 04:41PM  
Sep-23-20 07:00AM  
Sep-14-20 02:27PM  
Sep-09-20 05:28PM  
Aug-14-20 03:01PM  
Aug-12-20 04:59PM  
04:10PM  
Jun-16-20 04:05PM  
Jun-12-20 11:24AM  
06:18AM  
01:06AM  
Jun-03-20 08:30AM  
May-21-20 08:30AM  
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PICKERING GRANTChief Executive OfficerJun 28Sale21.0010,000210,000345,660Jun 28 05:14 PM
PICKERING GRANTChief Executive OfficerJun 24Sale21.0174715,696694,456Jun 28 05:14 PM
PICKERING GRANTChief Executive OfficerJun 23Sale21.013,54174,410695,203Jun 23 05:48 PM
PICKERING GRANTChief Executive OfficerJun 22Sale21.011,26126,492698,744Jun 23 05:48 PM
PICKERING GRANTChief Executive OfficerJun 21Sale21.055,451114,736700,005Jun 23 05:48 PM
Sauer PaulSVP Process Dev, ManufacturingMay 23Sale26.223,00078,67023,687May 25 04:24 PM
Fairman JeffVP, ResearchMay 20Sale25.504,112104,856321,227May 24 04:32 PM
GUGGENHIME ANDREWPresident and CFOMay 18Option Exercise5.353,10016,58545,287May 20 05:01 PM
GUGGENHIME ANDREWPresident and CFOMay 18Sale24.443,10075,76342,187May 20 05:01 PM
PICKERING GRANTChief Executive OfficerMay 16Option Exercise1.7911,00019,690714,894May 18 04:39 PM
PICKERING GRANTChief Executive OfficerMay 16Sale23.9111,000262,990703,894May 18 04:39 PM
Fairman JeffVP, ResearchMay 05Sale25.8088822,914325,339May 09 04:35 PM
Sauer PaulSVP Process Dev, ManufacturingApr 22Sale25.003,00075,00025,125Apr 26 05:18 PM
Wassil JimChief Operating OfficerApr 18Option Exercise2.422,8006,77645,744Apr 20 04:56 PM
PICKERING GRANTChief Executive OfficerApr 18Option Exercise1.7911,00019,690714,894Apr 20 04:54 PM
GUGGENHIME ANDREWPresident and CFOApr 18Option Exercise5.353,10016,58543,725Apr 20 04:55 PM
PICKERING GRANTChief Executive OfficerApr 18Sale23.9811,000263,766703,894Apr 20 04:54 PM
GUGGENHIME ANDREWPresident and CFOApr 18Sale24.053,10074,54240,625Apr 20 04:55 PM
Wassil JimChief Operating OfficerApr 18Sale23.982,80067,13042,944Apr 20 04:56 PM
Fairman JeffVP, ResearchApr 05Sale25.595,000127,950326,227Apr 07 05:24 PM
PICKERING GRANTChief Executive OfficerMar 22Option Exercise1.797,71213,804711,606Mar 23 06:03 PM
PICKERING GRANTChief Executive OfficerMar 22Sale24.627,712189,862703,894Mar 23 06:03 PM
Sauer PaulSVP Process Dev, ManufacturingMar 22Sale25.003,00075,00028,125Mar 24 06:05 PM
PICKERING GRANTChief Executive OfficerMar 21Option Exercise1.7914,28825,576718,182Mar 23 06:03 PM
PICKERING GRANTChief Executive OfficerMar 21Sale24.9414,288356,281703,894Mar 23 06:03 PM
GUGGENHIME ANDREWPresident and CFOMar 18Option Exercise5.353,10016,58543,725Mar 22 04:22 PM
GUGGENHIME ANDREWPresident and CFOMar 18Sale26.133,10080,99340,625Mar 22 04:22 PM
Fairman JeffVP, ResearchMar 11Sale25.5010,000255,000331,227Mar 15 09:09 PM
Sauer PaulSVP Process Dev, ManufacturingMar 10Sale25.006,000150,00031,125Mar 14 05:03 PM
GUGGENHIME ANDREWPresident and CFOMar 01Option Exercise5.356,20033,1709,325Mar 03 04:39 PM
GUGGENHIME ANDREWPresident and CFOMar 01Sale24.006,200148,8003,125Mar 03 04:39 PM
Wassil JimChief Operating OfficerFeb 24Option Exercise2.4210,00024,20027,944Feb 28 05:17 PM
Wassil JimChief Operating OfficerFeb 24Sale22.0010,000220,00017,944Feb 28 05:17 PM
Sauer PaulSVP Process Dev, ManufacturingDec 29Sale25.006,000150,00027,125Dec 30 04:36 PM
Fairman JeffVP, ResearchDec 27Option Exercise1.794,7508,50210,910Dec 28 04:15 PM
PICKERING GRANTChief Executive OfficerDec 27Option Exercise1.8051,76592,995632,019Dec 28 04:14 PM
Fairman JeffVP, ResearchDec 27Sale23.604,750112,0926,160Dec 28 04:15 PM
GUGGENHIME ANDREWPresident and CFODec 23Option Exercise5.353,10016,5856,225Dec 28 04:13 PM
GUGGENHIME ANDREWPresident and CFODec 23Sale24.003,10074,4003,125Dec 28 04:13 PM
Fairman JeffVP, ResearchDec 20Option Exercise1.794,4698,00010,629Feb 08 05:27 PM
Fairman JeffVP, ResearchDec 16Option Exercise1.794,6198,26810,779Dec 20 04:35 PM
Fairman JeffVP, ResearchDec 16Sale22.504,619103,9286,160Dec 20 04:35 PM
Fairman JeffVP, ResearchDec 09Option Exercise1.791312346,291Dec 13 05:20 PM
Fairman JeffVP, ResearchDec 09Sale22.501312,9486,160Dec 13 05:20 PM
PICKERING GRANTChief Executive OfficerNov 19Option Exercise1.7915,00026,850595,254Nov 23 05:10 PM
PICKERING GRANTChief Executive OfficerNov 19Sale23.4515,000351,710580,254Nov 23 05:10 PM
GUGGENHIME ANDREWPresident and CFONov 18Option Exercise5.353,10016,5856,225Nov 22 04:58 PM
GUGGENHIME ANDREWPresident and CFONov 18Sale24.533,10076,0303,125Nov 22 04:58 PM
Sauer PaulSVP Process Dev, ManufacturingNov 01Sale25.003,00075,00033,125Nov 03 05:55 PM
Fairman JeffVP, ResearchOct 26Option Exercise1.794,7508,5029,894Oct 28 06:00 PM
Fairman JeffVP, ResearchOct 26Sale22.694,750107,7785,144Oct 28 06:00 PM
PICKERING GRANTChief Executive OfficerOct 20Option Exercise1.7915,00026,850595,254Oct 22 04:46 PM
PICKERING GRANTChief Executive OfficerOct 20Sale22.5815,000338,756580,254Oct 22 04:46 PM
Fairman JeffVP, ResearchSep 27Option Exercise1.794,7508,5029,894Sep 29 07:52 PM
Fairman JeffVP, ResearchSep 27Sale26.174,750124,3035,144Sep 29 07:52 PM
PICKERING GRANTChief Executive OfficerSep 22Option Exercise1.794,1937,505584,447Sep 23 05:40 PM
Sauer PaulSVP Process Dev, ManufacturingSep 22Sale25.205,307133,72436,125Sep 24 05:04 PM
PICKERING GRANTChief Executive OfficerSep 22Sale25.194,193105,636580,254Sep 23 05:40 PM
PICKERING GRANTChief Executive OfficerSep 21Option Exercise1.7910,80719,345591,061Sep 23 05:40 PM
PICKERING GRANTChief Executive OfficerSep 21Sale25.2210,807272,590580,254Sep 23 05:40 PM
Fairman JeffVP, ResearchAug 26Option Exercise1.794,7508,5029,894Aug 30 06:06 PM
Fairman JeffVP, ResearchAug 26Sale25.384,750120,5435,144Aug 30 06:06 PM
PICKERING GRANTChief Executive OfficerAug 23Option Exercise1.7913,66924,468593,923Aug 25 06:11 PM
PICKERING GRANTChief Executive OfficerAug 23Sale22.7313,669310,722580,254Aug 25 06:11 PM
PICKERING GRANTChief Executive OfficerAug 19Option Exercise1.791,3312,382581,585Aug 20 04:19 PM
PICKERING GRANTChief Executive OfficerAug 19Sale22.401,33129,810580,254Aug 20 04:19 PM
Wright-Mitchell JaneGeneral CounselAug 16Option Exercise2.032,5005,0755,625Aug 18 06:02 PM
Wright-Mitchell JaneGeneral CounselAug 16Sale26.002,50065,0003,125Aug 18 06:02 PM
Wright-Mitchell JaneGeneral CounselAug 12Option Exercise2.0310,00020,30013,125Aug 16 04:31 PM
Wright-Mitchell JaneGeneral CounselAug 12Sale26.0010,000260,0003,125Aug 16 04:31 PM
Fairman JeffVP, ResearchJul 26Option Exercise1.794,7508,5029,894Jul 28 04:32 PM
Fairman JeffVP, ResearchJul 26Sale22.704,750107,8255,144Jul 28 04:32 PM
PICKERING GRANTChief Executive OfficerJul 20Option Exercise1.7915,00026,850595,254Jul 22 04:58 PM
PICKERING GRANTChief Executive OfficerJul 20Sale22.8515,000342,686580,254Jul 22 04:58 PM